Cargando…
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system
OBJECTIVES: To measure and explain financial toxicity (FT) of cancer in Italy, where a public healthcare system exists and patients with cancer are not expected (or only marginally) to pay out-of-pocket for healthcare. SETTING: Ten clinical oncological centres, distributed across Italian macroregion...
Autores principales: | Riva, Silvia, Arenare, Laura, Di Maio, Massimo, Efficace, Fabio, Montesarchio, Vincenzo, Frontini, Luciano, Giannarelli, Diana, Bryce, Jane, Del Campo, Laura, De Lorenzo, Francesco, Iannelli, Elisabetta, Traclò, Francesca, Gitto, Lara, Jommi, Claudio, Vaccaro, Concetta Maria, Barberio, Daniela, Cinieri, Saverio, Porta, Camillo, Del Mastro, Lucia, Zagonel, Vittorina, Cogoni, Alessio Aligi, Bordonaro, Roberto, Gimigliano, Anna, Piccirillo, Maria Carmela, Guizzaro, Lorenzo, Gallo, Ciro, Perrone, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529986/ https://www.ncbi.nlm.nih.gov/pubmed/34670762 http://dx.doi.org/10.1136/bmjopen-2021-049128 |
Ejemplares similares
-
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol
por: Riva, Silvia, et al.
Publicado: (2019) -
To William Proffit, a Brazilian farewell
por: Artese, Flávia, et al.
Publicado: (2018) -
The opportunity of patient-journey studies for academic clinical research in oncology
por: Perrone, Francesco, et al.
Publicado: (2021) -
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations
por: Caccialanza, Riccardo, et al.
Publicado: (2022) -
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan
por: Chiodini, Paolo, et al.
Publicado: (2020)